H1N1 triggers £1.4m Scottish investment in ventilators
This article was originally published in Clinica
Scotland is to purchase 40 adult and 15 paediatric ventilators, worth £1.4m ($2.3m), as part of plans to prepare for any major surge in H1N1 influenza cases. The critical care action plan also envisages increasing intensive care capacity from 180 to 378 adults, and doubling paediatric capacity.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.